Search results
Results From The WOW.Com Content Network
Aerie Pharmaceuticals Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. Aerie's two lead product candidates are once-daily therapies for lowering intraocular pressure with mechanisms to treat patients ...
Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
Website. roivant .com. Footnotes / references. Financials as of 31 March 2024. [update] [1] [2] Roivant Sciences Ltd. is a healthcare company focused on applying technology to drug development and building subsidiary biotech and healthcare technology companies. It was founded in 2014 by Vivek Ramaswamy .
Shares of Aerie Pharmaceuticals surged 16.3% on Feb. 26 after the ophthalmic pharmaceutical company’s 4Q revenue topped the Street’s estimates. Revenue in the fourth quarter surged 23% ...
Aerie (AERI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
It was a rough fourth quarter for many hedge funds, which were naturally unable to overcome the big dip in the broad market, as the S&P 500 fell by about 4.8% during 2018 and average hedge fund ...
Israel had more companies listed in 2012 on the NASDAQ stock exchange than any country outside of the United States and China. [1] [2] As of 2011, some sixty Israeli companies are listed on the Nasdaq. [3] 2000 was the year that saw the most new Israeli listings on the exchange – 33 companies. [4] Through the years, many have been acquired ...
Let us take a look at five biotech/drug companies, namely, MRNA, EDIT, VIR, EBS and AERI, which are due to release their quarterly results on Feb 24. Drug/Biotech Stocks' Q4 Earnings on Feb 24 ...